TFEB and breast carcinoma: Under standard culture conditions endogenous TFEB was localized to the cytoplasm in the breast cancer cell line MCF7, but was relocated to the nucleus on addition of the mTOR inhibitor Torin 1 (Fig. 1a), indicating that in these cells mTOR controls TFEB localization.